Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 6)

What is the purpose of this trial?

The study is performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care


Participation Guidelines

Ages: 18 years and older

Gender: Female only


Bayer Healthcare Pharmaceuticals, Inc.

Start Date: 04/18/2018

End Date: 12/31/2018

Last Updated: 06/20/2018

Study HIC#: 2000021011

Get Involved

For more information about this study, contact:
Kristin DeFrancesco
+1 203-785-3852
kristin.defrancesco@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Pinar Kodaman

Principal Investigator

Sub-Investigators